Pacira BioSciences, Inc.PCRXNASDAQ
Loading
EPS Diluted Over TimeExpanding
Percentile Rank71
3Y CAGR-24.2%
5Y CAGR-46.3%
Studio
Year-over-Year Change

Diluted earnings per share

3Y CAGR
-24.2%/yr
Annual compound
5Y CAGR
-46.3%/yr
Recent acceleration
Percentile
P71
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM0.15+106.9%
2024-2.15-341.6%
20230.89+161.8%
20220.34-63.0%
20210.92-72.4%
20203.33+1333.3%
2019-0.27-2247.8%
2018-0.01+98.9%
2017-1.07-4.9%
2016-1.02-